Free Trial

Biophytis (BPTSY) Competitors

$1.70 -0.24 (-12.37%)
As of 05/22/2025 09:30 AM Eastern

BPTSY vs. PWUP, INM, QLGN, KTTA, VCNX, PTN, AWH, SCNI, APVO, and GLMD

Should you be buying Biophytis stock or one of its competitors? The main competitors of Biophytis include PowerUp Acquisition (PWUP), InMed Pharmaceuticals (INM), Qualigen Therapeutics (QLGN), Pasithea Therapeutics (KTTA), Vaccinex (VCNX), Palatin Technologies (PTN), Aspira Women's Health (AWH), Scinai Immunotherapeutics (SCNI), Aptevo Therapeutics (APVO), and Galmed Pharmaceuticals (GLMD). These companies are all part of the "pharmaceutical products" industry.

Biophytis vs.

Biophytis (NASDAQ:BPTSY) and PowerUp Acquisition (NASDAQ:PWUP) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, community ranking, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BiophytisN/AN/A-$18.43MN/AN/A
PowerUp AcquisitionN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BiophytisN/A N/A N/A
PowerUp Acquisition N/A N/A N/A

0.1% of Biophytis shares are held by institutional investors. Comparatively, 19.2% of PowerUp Acquisition shares are held by institutional investors. 3.7% of Biophytis shares are held by company insiders. Comparatively, 48.0% of PowerUp Acquisition shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Biophytis' average media sentiment score of 0.00 equaled PowerUp Acquisition'saverage media sentiment score.

Company Overall Sentiment
Biophytis Neutral
PowerUp Acquisition Neutral

Biophytis has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500. Comparatively, PowerUp Acquisition has a beta of 0.05, suggesting that its stock price is 95% less volatile than the S&P 500.

Biophytis and PowerUp Acquisition both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
BiophytisN/AN/A
PowerUp AcquisitionN/AN/A

Summary

PowerUp Acquisition beats Biophytis on 2 of the 3 factors compared between the two stocks.

Get Biophytis News Delivered to You Automatically

Sign up to receive the latest news and ratings for BPTSY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BPTSY vs. The Competition

MetricBiophytisPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$597,000.00$6.47B$5.33B$8.39B
Dividend YieldN/A2.64%5.21%4.11%
P/E RatioN/A9.0626.8019.71
Price / SalesN/A251.66397.78120.67
Price / CashN/A65.8538.2534.62
Price / Book-0.116.456.774.50
Net Income-$18.43M$143.98M$3.23B$248.22M
7 Day PerformanceN/A0.38%0.48%-0.78%
1 Month Performance-49.40%2.14%9.13%11.53%
1 Year Performance-77.69%-0.33%18.58%8.99%

Biophytis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BPTSY
Biophytis
N/A$1.70
-12.4%
N/A-77.7%$597,000.00N/A0.0030
PWUP
PowerUp Acquisition
N/A$0.36
+6.3%
N/A-98.1%$2.77MN/A0.00N/AHigh Trading Volume
INM
InMed Pharmaceuticals
0.4091 of 5 stars
$2.28
-3.0%
N/A-60.6%$2.75M$4.83M-0.1710Positive News
Gap Down
QLGN
Qualigen Therapeutics
N/A$3.65
+1.7%
N/A-72.9%$2.69M$4.98M0.0050
KTTA
Pasithea Therapeutics
1.5901 of 5 stars
$0.87
+4.7%
N/A-85.7%$2.57MN/A-0.073
VCNX
Vaccinex
N/A$0.98
+44.1%
N/A-87.8%$2.55M$388,000.00-0.0240Gap Up
PTN
Palatin Technologies
N/A$0.09
-44.6%
N/AN/A$2.45M$350,000.00-0.0630Analyst Forecast
Gap Down
High Trading Volume
AWH
Aspira Women's Health
0.9259 of 5 stars
$0.08
-12.5%
$5.50
+6,607.3%
-96.8%$2.44M$9.18M-0.07110High Trading Volume
SCNI
Scinai Immunotherapeutics
0.2795 of 5 stars
$2.54
-1.6%
N/A-17.7%$2.41M$452,000.00-0.0120News Coverage
APVO
Aptevo Therapeutics
2.1491 of 5 stars
$0.34
flat
$10,952.00
+3,221,076.5%
-100.0%$2.13M$3.11M0.0050News Coverage
Gap Down
GLMD
Galmed Pharmaceuticals
0.8018 of 5 stars
$1.28
+3.2%
N/A-70.4%$2.12MN/A-0.0820News Coverage
Earnings Report
Upcoming Earnings
Gap Down

Related Companies and Tools


This page (NASDAQ:BPTSY) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners